tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

OCGN Stock Latest News

Ocugen management to meet with Maxim
The FlyOcugen management to meet with Maxim
19d ago
OCGN
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
1M ago
PTN
SNY
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
1M ago
ALLR
ALNY
Ocugen’s Strategic Advancements and Promising Developments Justify Buy Rating
PremiumRatings
Ocugen’s Strategic Advancements and Promising Developments Justify Buy Rating
1M ago
OCGN
Ocugen says DSMB approves dosing Cohort 2 in OCU200 clinical trial
PremiumThe Fly
Ocugen says DSMB approves dosing Cohort 2 in OCU200 clinical trial
1M ago
OCGN
Ocugen’s Strategic Advancements and Financial Stability Justify Buy Rating
PremiumRatingsOcugen’s Strategic Advancements and Financial Stability Justify Buy Rating
2M ago
OCGN
Ocugen’s Strategic BLA Submissions and Financial Position Support Buy Rating
Premium
Ratings
Ocugen’s Strategic BLA Submissions and Financial Position Support Buy Rating
2M ago
OCGN
Ocugen Inc. Navigates Uncertainty Amid Potential Shifts in U.S. Fiscal and Tax Policies
Premium
Company Announcements
Ocugen Inc. Navigates Uncertainty Amid Potential Shifts in U.S. Fiscal and Tax Policies
2M ago
OCGN
Ocugen Reports Progress in Gene Therapy Trials
PremiumCompany Announcements
Ocugen Reports Progress in Gene Therapy Trials
2M ago
OCGN
Ocugen Inc Earnings Call: Strategic Gains Amid Financial Challenges
PremiumCompany Announcements
Ocugen Inc Earnings Call: Strategic Gains Amid Financial Challenges
2M ago
OCGN
OCGN Earnings: Ocugen Stock Jumps on Q4 Results & Development Updates
PremiumMarket News
OCGN Earnings: Ocugen Stock Jumps on Q4 Results & Development Updates
2M ago
OCGN
Ocugen reports Q4 EPS (5c), consensus (5c)
PremiumThe Fly
Ocugen reports Q4 EPS (5c), consensus (5c)
2M ago
OCGN
Options Volatility and Implied Earnings Moves Today, March 05, 2025
PremiumMarket NewsOptions Volatility and Implied Earnings Moves Today, March 05, 2025
2M ago
FL
ZS
Ocugen announces EC provided position opinion from EMA’s CAT for OCU410
Premium
The Fly
Ocugen announces EC provided position opinion from EMA’s CAT for OCU410
2M ago
OCGN
Options Volatility and Implied Earnings Moves This Week, March 03 – March 06, 2025
Premium
Market News
Options Volatility and Implied Earnings Moves This Week, March 03 – March 06, 2025
2M ago
M
SE
Ocugen Inc (OCGN) Q4 Earnings Cheat Sheet
PremiumPre-Earnings
Ocugen Inc (OCGN) Q4 Earnings Cheat Sheet
2M ago
OCGN
Ocugen reports FDA alignment on Phase 2/3 OCU410ST trial in Stargardt disease
PremiumThe Fly
Ocugen reports FDA alignment on Phase 2/3 OCU410ST trial in Stargardt disease
2M ago
OCGN
Buy Rating for Ocugen Based on Promising OCU410 Study Progress and Geographic Atrophy Treatment Potential
PremiumRatings
Buy Rating for Ocugen Based on Promising OCU410 Study Progress and Geographic Atrophy Treatment Potential
2M ago
OCGN
Ocugen price target raised to $8 from $7 at H.C. Wainwright
PremiumThe Fly
Ocugen price target raised to $8 from $7 at H.C. Wainwright
2M ago
OCGN
Ocugen announces dosing completion in Phase 2 ArMaDa clinical trial
PremiumThe FlyOcugen announces dosing completion in Phase 2 ArMaDa clinical trial
2M ago
OCGN
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
3M ago
HL
ARBE
Ocugen’s OCU400 granted positive opinion by EMA in retinitis pigmentosa
Premium
The Fly
Ocugen’s OCU400 granted positive opinion by EMA in retinitis pigmentosa
3M ago
OCGN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >